Supriya Lifescience Ltd Q1 FY2024 net profit at Rs. 2.85 crore

Supriya Lifescience Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 13.4938 crores during the period ended June 30, 2023 as compared to Rs. 14.4235 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 2.8511 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.8229 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 3.54 for the period ended June 30, 2023 as compared to Rs. 4.75 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 13.4938 crs	₹14.4235 crs	-6.45%
Net Profit	₹2.8511 crs	₹3.8229 crs	-25.42%
EPS	₹3.54	₹4.75	-25.47%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 13.4938 crores during the period ended June 30, 2023 as compared to Rs.10.3712 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.2.8511 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.2.5249 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.3.54 for the period ended June 30, 2023 as compared to Rs.3.14 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 13.4938 crs	₹10.3712 crs	30.11%
Net Profit	₹2.8511 crs	₹2.5249 crs	12.92%
EPS	₹3.54	₹3.14	12.74%

Shares of Supriya Lifescience Limited was last trading in BSE at Rs. 278.80 as compared to the previous close of Rs. 274.85. The total number of shares traded during the day was 92057 in over 2588 trades.

The stock hit an intraday high of Rs. 287.65 and intraday low of 275.00. The net turnover during the day was Rs. 25927591.00.

Source : Equity Bulls

Keywords

SupriyaLifescience Q1FY24 ResultUpdate